Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Tanioka, Maki M; Fan, Cheng C; Parker, Joel S JS; Hoadley, Katherine A KA; Hu, Zhiyuan Z; Li, Yan Y; Hyslop, Terry M TM; Pitcher, Brandelyn N BN; Soloway, Matthew G MG; Spears, Patricia A PA; Henry, Lynn N LN; Tolaney, Sara S; Dang, Chau T CT; Krop, Ian E IE; Harris, Lyndsay N LN; Berry, Donald A DA; Mardis, Elaine R ER; Winer, Eric P EP; Hudis, Clifford A CA; Carey, Lisa A LA; Perou, Charles M CM